Loading data
GCTKNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 9.81 m USD | 9.5 m USD | 4.7 m USD | 1.97 m USD | 1.81 m USD |
| Operating profit | -16.09 m USD | -14.55 m USD | -7.1 m USD | -4.43 m USD | -4.04 m USD |
| Interest expense | — | 44 k USD | — | — | — |
| Net income (reported basis) | -19.39 m USD | -22.58 m USD | -7.1 m USD | 4.41 m USD | -4.07 m USD |
| Net income attributable to common shareholders | — | -22.6 m USD | -7.95 m USD | 4.44 m USD | — |
| Basic earnings per share | 31.22 USD/share | 4,106 USD/share | 34.18 USD/share | 0.29 USD/share | 0.26 USD/share |
| Diluted earnings per share | 31.22 USD/share | 4,106 USD/share | 34.18 USD/share | 0.29 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.